Southwest oncology group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

Derick H. Lau, John J. Crowley, David R. Gandara, Mark B. Hazuka, Kathy S. Albain, Bryan Leigh, William S. Fletcher, Keith S. Lanier, Wayne L. Keiser, Robert B. Livingston

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint Dive into the research topics of 'Southwest oncology group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences